Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia

NCT00232102 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
423
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis